According to a new market research study of “Europe Autotransfusion Devices Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Application and End-User, the Europe autotransfusion devices is projected to reach US$ 357.31 million by 2027 from US$ 273.87 million in 2019. The market is estimated to grow at CAGR of 3.5% from 2020 to 2027. The report highlights trends prevailing in the Europe autotransfusion Devices market and the factors driving market along with those that act as hindrances.
Based on type, the Europe Autotransfusion Devices market is further segmented into products and accessories. The product segment held the largest share of the market in 2019. However, the Accessories segment is estimated to register the highest CAGR in the market during the forecast period. The autotransfusion products comprises a system that operates in combination with various components, such as wash kits, vacuum pump, transfer bags, and others. Autotransfusion products are easy to use, and a few are fully automated. For example, the autoLog autotransfusion system by Medtronic is fully automated. It operates in a two-stage filling cycle the initial stage and final stage. This two-stage processing helps in the smooth transition of blood flow during the process. The system is fitted with a level sensor that controls and monitors the red cell pack level. The product segment is further categorized into intraoperative autotransfusion system, postoperative autotransfusion system, dual mode autotransfusion system.
Europe autotransfusion devices market is expected to grow owing to factors such as growth include involvement of rare blood groups, and rising prevalence of chronic diseases. Whereas, the market is likely to have negative impact due to the, risks associated with autotransfusion.
Zimmer Biomet, BD, Teleflex Incorporated, Fresenius SE & Co. KGaA, Medtronic, are among the leading companies operating in the Europe autotransfusion devices market.
The report segments in Europe Autotransfusion Devices market as follows:
By Type
By Application
By End User
By Country
Reasons to Buy
Based on type, the Europe Autotransfusion Devices market is further segmented into products and accessories. The product segment held the largest share of the market in 2019. However, the Accessories segment is estimated to register the highest CAGR in the market during the forecast period. The autotransfusion products comprises a system that operates in combination with various components, such as wash kits, vacuum pump, transfer bags, and others. Autotransfusion products are easy to use, and a few are fully automated. For example, the autoLog autotransfusion system by Medtronic is fully automated. It operates in a two-stage filling cycle the initial stage and final stage. This two-stage processing helps in the smooth transition of blood flow during the process. The system is fitted with a level sensor that controls and monitors the red cell pack level. The product segment is further categorized into intraoperative autotransfusion system, postoperative autotransfusion system, dual mode autotransfusion system.
Europe autotransfusion devices market is expected to grow owing to factors such as growth include involvement of rare blood groups, and rising prevalence of chronic diseases. Whereas, the market is likely to have negative impact due to the, risks associated with autotransfusion.
Zimmer Biomet, BD, Teleflex Incorporated, Fresenius SE & Co. KGaA, Medtronic, are among the leading companies operating in the Europe autotransfusion devices market.
The report segments in Europe Autotransfusion Devices market as follows:
By Type
- Product
- Intraoperative Autotransfusion Systems
- Postoperative Autotransfusion Systems
- Dual-Mode Autotransfusion Systems
- Accessories
By Application
- Cardiac Surgeries
- Orthopaedic Surgeries
- Organ Transplantation
- Trauma Procedures
- Others
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
By Country
- France
- Germany
- UK
- Italy
- Spain
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe autotransfusion devices market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe autotransfusion devices market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Europe Autotransfusion Devices Market - Market Landscape
5. Europe Autotransfusion Devices Market - Key Market Dynamics
6. Autotransfusion Devices Market - Europe Analysis
7. Europe Autotransfusion Devices Market Analysis and Forecasts to 2027 - by Type
8. Europe Autotransfusion Devices Market Analysis? by Application
9. Europe Autotransfusion Devices Market Analysis? by End-User
10. Autotransfusion Devices Market Revenue and Forecasts to 2027 ? Geographical Analysis
11. Europe Autotransfusion Devices Market Industry Landscape
12. Autotransfusion Devices Market ? Key Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BD
- Braile Biomedica
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- LivaNova PLC
- Medtronic
- Redax S.p.A.
- SARSTEDT AG and Co. KG
- Teleflex Incorporated
- Zimmer Biomet